Sunil, Hari Shankar https://orcid.org/0000-0002-4416-3720
Clemenceau, Jean R https://orcid.org/0000-0002-6222-6457
Grichuk, Anthony
Barnfather, Isabel https://orcid.org/0009-0007-3071-963X
Nakkireddy, Sumanth R
Izzo, Luke https://orcid.org/0000-0002-6217-9240
Feng, Qiang https://orcid.org/0000-0002-3665-3914
Hartnett, William
Evers, Bret M https://orcid.org/0000-0001-5686-0315
Thomas, Lisa
Subramaniyan, Indhumathy
Li, Li
Putnam, William C https://orcid.org/0000-0001-9338-4143
Hepensteil, Steven https://orcid.org/0009-0003-8154-4797
Zhu, Jingfei
Updegraff, Barrett
Minna, John D https://orcid.org/0000-0002-7776-0767
DeBerardinis, Ralph J https://orcid.org/0000-0002-2705-7432
Hwang, Tae Hyun https://orcid.org/0000-0002-6668-7269
Gao, Jinming https://orcid.org/0000-0003-0726-5098
Oliver, Trudy G https://orcid.org/0000-0003-2082-2397
O’Donnell, Kathryn A https://orcid.org/0000-0003-2215-1064
Funding for this research was provided by:
HHS | NIH | National Cancer Institute (R01CA273585)
HHS | NIH | National Cancer Institute (R01CA207763)
HHS | NIH | National Cancer Institute (P50CA70907)
HHS | NIH | National Cancer Institute (U24CA213274)
HHS | NIH | National Cancer Institute (R01CA244841-05)
Cancer Prevention and Research Institute of Texas (RP190610)
Cancer Prevention and Research Institute of Texas (RP200327)
Cancer Prevention and Research Institute of Texas (RP250391)
Cancer Prevention and Research Institute of Texas (RP250572)
Welch Foundation (I-1881)
V Foundation for Cancer Research (T2021-011)
U.S. Department of Defense (LC190249)
American Lung Association (LCD1421064)
Article History
Received: 14 April 2025
Revised: 20 October 2025
Accepted: 24 October 2025
First Online: 10 November 2025
Disclosure and competing interests statement
: KAO is a scientific co-founder and owns stock in ProtomAb Therapeutics, Inc. The remaining authors declare no competing interests.